Editorial Board disclosures
Chief Editor
John R. Hurst reports receiving grants, personal fees and non-financial support from pharmaceutical companies that make medicines to treat respiratory disease. This includes reimbursement for educational activities and advisory work, and support to attend meetings.
Mohammed AlAhmari has nothing to disclose.
Sinthia Bosnic-Anticevich has nothing to disclose.
Irene Heijink reports receiving research grants from pharmaceutical companies.
Bruce Kirenga has nothing to disclose.
Sheila Ramjug's MD research was part-funded by Actelion.